Consistent with the general trend of incorporating artificial intelligence into nearly every field, researchers and politicians are increasingly using AI models trained on scientific data to infer ...
Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on private pharmaceutical infrastructure CAMBRIDGE, Mass., March 3, 2026 ...
Liquid AI and Insilico Medicine today announced a partnership that creates lightweight scientific foundation models for pharmaceutical research. The collaboration has produced LFM2-2.6B-MMAI (v0.2.1), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results